论文信息 - CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) - 字舞流文

CAMIDANLUMAB TESIRINE EFFICACY AND SAFETY IN AN OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS (PTS) WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

K. Savage | J. Radford | S. Ansell | P. Zinzani | J. Wuerthner | N. Bartlett | C. Carlo-Stella | P. Caimi | J. Kline | A. Herrera | G. Collins | M. Hamadani | K. Maddocks | H. Cruz | L. Wang | Y. Negievich